Privigen 10% vial 200ML
Ended Awarded Last action
- Contract number
- SPE2DR26FRRE2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,963
Award facts
- Contract value 100% obligated
- $13,963.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On November 24, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,963.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The delivery order calls for the supply of PRIVIGEN 10% Vial 200ML, a critical immunoglobulin replacement therapy used in military healthcare settings. This award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The contract is scheduled for ultimate completion by December 16, 2025, with performance taking place at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, carries a $499.9 billion ceiling value and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. DMS Pharmaceutical Group serves as one of multiple regional prime vendor contractors under this program, positioning the company as a critical supplier of branded and generic prescription medications, biologics, and medical consumables supporting military medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FRRE2?
SPE2DR26FRRE2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FRRE2 worth?
The government has obligated $13,963 on SPE2DR26FRRE2.
Is contract SPE2DR26FRRE2 an order under another contract?
Yes. SPE2DR26FRRE2 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.
Was contract SPE2DR26FRRE2 competed?
The extent of competition for SPE2DR26FRRE2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award